Total Results: 6
Groene, Emily A.; Norby, Faye L.; Eaton, Anne A.; Mason, Susan M.; Enns, Eva A.; Kulasingam, Shalini; Vock, David M.
2023.
Diagnosed Gonorrhea Among Privately Insured Women: Analysis of United States Claims Data.
Abstract
|
Full Citation
|
Google
Background: Gonorrhea incidence in the United States has risen by nearly 50% in the last decade, while screening rates have increased. Gonorrhea sequelae rates could indicate whether increased gono...
Groene, Emily A.; Norby, Faye L.; Eaton, Anne A.; Mason, Susan M.; Enns, Eva A.; Kulasingam, Shalini; Vock, David M.
2023.
Diagnosed Gonorrhea Among Privately Insured Women: Analysis of United States Claims Data.
Abstract
|
Full Citation
|
Google
Background: Gonorrhea incidence in the United States has risen by nearly 50% in the last decade, while screening rates have increased. Gonorrhea sequelae rates could indicate whether increased gono...
Yared, Nicholas; Malone, Molly; Welo, Estee; Mohammed, Inari; Groene, Emily A; Flory, Matthew; Basta, Nicole E; Horvath, Keith J.; Kulasingam, Shalini L
2021.
Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives.
Abstract
|
Full Citation
|
Google
Human papillomavirus (HPV) vaccination rates among adolescents are increasing in Minnesota (MN) but remain below the Healthy People 2020 goal of 80% completion of the series. The goal of this study was to identify messaging and interventions impacting HPV vaccine uptake in MN through interviews with clinicians and key stakeholders. We conducted semi-structured key participant interviews with providers and stakeholders involved in HPV vaccination efforts in MN between 2018 and 2019. Provider interview questions focused on messaging around the HPV vaccine and clinic-based strategies to impact HPV vaccine uptake. Stakeholder interview questions focused on barriers and facilitators at the organizational or state level, as well as initiatives and collaborations to increase HPV vaccination. Responses to interviews were recorded and transcribed. Thematic content analysis was used to identify themes from interviews. 14 clinicians and 13 stakeholders were interviewed. Identified themes were grouped into 2 major categories that dealt with messaging around the HPV vaccine, direct patient–clinician interactions and external messaging, and a third thematic category involving healthcare system-related factors and interventions. The messaging strategy identified as most useful was promoting the HPV vaccine for cancer prevention. The need for stakeholders to prioritize HPV vaccination uptake was identified as a key factor to increasing HPV vaccination rates. Multiple providers and stakeholders identified misinformation spread through social media as a barrier to HPV vaccine uptake. Emphasizing the HPV vaccine’s cancer prevention benefits and prioritizing it among healthcare stakeholders were the most consistently cited strategies for promoting HPV vaccine uptake. Methods to combat the negative influence of misinformation about HPV vaccines in social media are an urgent priority.
Burger, Emily A; de Kok, Inge M C M; Groene, Emily A; Killen, James; Canfell, Karen; Kulasingam, Shalini L; Kuntz, Karen M; Matthijsse, Suzette; Regan, Catherine; Simms, Kate; Smith, Megan; Sy, Stephen; Alarid-Escudero, Fernando; Vaidyanathan, Vivek; van Ballegooijen, Marjolein; Kim, Jane J
2019.
Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis.
Abstract
|
Full Citation
|
Google
Groene, Emily A; Mohammed, Inari; Horvath, Keith J.; Basta, Nicole E; Yared, Nicholas
2019.
Online media scans : Applying systematic review techniques to assess statewide human papillomavirus vaccination activities on om m er ci us e on m er al.
Abstract
|
Full Citation
|
Google
Groene, Emily A; Boraas, Christy M; Smith, M Kumi; Lofgren, Sarah M; Rothenberger, Meghan K; Enns, Eva A; Author, Corresponding
Evaluation of Strategies to Improve Uptake of Expedited Partner Therapy for Chlamydia trachomatis Treatment in Minnesota: A Decision Analytic Model.
Abstract
|
Full Citation
|
Google
Background. Despite the established effectiveness of expedited partner therapy (EPT) in partner treatment of bacterial sexually transmitted infections (STI), the practice is underutilized. Objective. To estimate the relative effectiveness of strategies to increase EPT uptake (numbers of partners treated for chlamydia). Methods. We developed a care cascade model of cumulative probabilities to estimate the number of partners treated under strategies to increase EPT uptake in Minnesota. The care cascade model used data from clinical trials, population-based studies, and Minnesota chlamydia surveillance as well as in-depth interviews of health providers who regularly treat STI patients and a statewide survey of health providers across Minnesota. Results. Several strategies could improve EPT uptake among providers, including facilitating treatment payment (additional 1,932 partners treated) and implementing electronic health record reminders (additional 1,755 partners treated). Addressing concerns about liability would have the greatest effect, resulting in 2,187 additional partners treated. Conclusions. Providers expressed openness to offering EPT under several scenarios, which reflect differences in knowledge about EPT, its legality, and potential risks to patients. While addressing concerns about provider liability would have the greatest effect on number of partners treated, provider education and procedural changes could make a substantial impact. Highlights Addressing provider concerns about expedited partner therapy (EPT) legality and its potential risks would result in the most partners treated for chlamydia. EPT alerts and electronic EPT prescriptions may also streamline partner treatment. Provider education about the legality of EPT and its potential risks and training in counseling patients on EPT could also increase uptake.
Total Results: 6